Aurora Cannabis Welcomes New CFO Simona King

LOS ANGELES- Aurora Cannabis Inc., a Canadia global medical cannabis industry, has announced the appointment of Simona King as its new Chief Financial Officer (CFO), effective February 21, 2024. King, a seasoned finance executive with over 25 years of experience, joins Aurora from Bristol Myers-Squibb, a leading global pharmaceutical company, where she played a pivotal role in finance leadership and company growth strategy for nearly two decades.

This strategic hire marks a significant transition for Aurora, as Simona King replaces Glen Ibbott, who will step down from his role on February 20 to explore new opportunities. Ibbott, who has been instrumental in guiding Aurora since 2017, will continue to serve in an advisory capacity in the coming months to facilitate a smooth transition.

Leadership Transition at a Pivotal Time

The leadership change comes at a critical juncture for Aurora, which aims to bolster its position in the rapidly evolving cannabis industry. Miguel Martin, CEO of Aurora, expressed enthusiasm for King’s arrival, citing her extensive background in business growth, operational efficiencies, and financial leadership as vital to the company’s next growth phase. Martin also extended gratitude to Ibbott for his significant contributions to Aurora’s development into a medical cannabis industry leader.

Simona King’s Financial Acumen

King’s vast experience encompasses a broad range of financial and operational roles, significantly enhancing her suitability for steering Aurora’s financial strategy. Her tenure at Bristol Myers-Squibb, marked by senior finance positions, underscores her capability in supporting growth strategies and operational excellence. Moreover, King’s recent involvement with clinical-stage biotechnology firms aligns with Aurora’s forward-looking approach to innovation and market expansion.

Aurora’s Strategic Share Consolidation

In conjunction with the leadership transition, Aurora has completed a share consolidation on a 10-to-1 basis, a move designed to streamline its capital structure. Starting February 20, Aurora’s common shares will trade on the Nasdaq and the Toronto Stock Exchange under the symbol “ACB”, reflecting the post-consolidation status. This financial maneuver is part of Aurora’s broader strategy to enhance shareholder value and position the company for long-term success.

The arrival of Simona King as CFO and the strategic share consolidation underscore Aurora Cannabis Inc.’s commitment to leadership excellence and financial stability. As the company continues to navigate the complexities of the global cannabis market, these strategic decisions are poised to fortify Aurora’s growth trajectory and operational efficiency, ensuring its competitive edge in the industry.